Published in JACC Cardiovasc Interv on November 01, 2009
Prevalence of conventional risk factors in patients with coronary heart disease. JAMA (2003) 6.84
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA (2011) 3.97
Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA (2012) 3.71
Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden. Circulation (2008) 2.34
Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv (2012) 1.73
Prognostic impact of a chronic total occlusion in a non-infarct-related artery in patients with ST-segment elevation myocardial infarction: 3-year results from the HORIZONS-AMI trial. Eur Heart J (2012) 1.57
Images in cardiovascular medicine. Tako-tsubo--like transient left ventricular dysfunction. Circulation (2003) 1.52
SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy. Catheter Cardiovasc Interv (2014) 1.45
Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: results from the INFUSE-AMI study. Catheter Cardiovasc Interv (2013) 1.45
Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial). Am J Cardiol (2013) 1.42
Long-term effect of chronic oral anticoagulation with warfarin after acute myocardial infarction. Am J Med (2010) 1.42
Femoral vascular closure device use, bivalirudin anticoagulation, and bleeding after primary angioplasty for STEMI: results from the HORIZONS-AMI trial. Catheter Cardiovasc Interv (2014) 1.40
Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction. JACC Cardiovasc Interv (2008) 1.37
Risks and complications of coronary angiography: a comprehensive review. Glob J Health Sci (2012) 1.32
Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial. J Am Coll Cardiol (2012) 1.09
The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol (2006) 1.09
In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? J Am Coll Cardiol (2007) 1.04
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes. Eur Heart J (2009) 1.04
Intralesional abciximab and thrombus aspiration in patients with large anterior myocardial infarction: one-year results from the INFUSE-AMI trial. Circ Cardiovasc Interv (2013) 1.02
Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization. Catheter Cardiovasc Interv (2004) 0.99
Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials. Am Heart J (2004) 0.97
Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am J Cardiol (2013) 0.95
Correlation between markers of reperfusion and mortality in ST-elevation myocardial infarction: a systematic review. J Invasive Cardiol (2014) 0.91
Radial versus femoral access. J Am Coll Cardiol (2013) 0.90
Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality. J Am Coll Cardiol (2008) 0.89
Initial strategy of revascularization versus optimal medical therapy for improving outcomes in ischemic heart disease: a review of the literature. Curr Cardiol Rep (2012) 0.87
Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention. Am Heart J (2011) 0.84
Determinants of bare-metal stent use in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. J Invasive Cardiol (2013) 0.83
Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial. EuroIntervention (2013) 0.82
Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. EuroIntervention (2013) 0.81
Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome. EuroIntervention (2015) 0.80
Influence of coronary artery stenosis severity and coronary collateralization on extent of chronic myocardial scar: insights from quantitative coronary angiography and delayed-enhancement MRI. Open Cardiovasc Med J (2008) 0.79
Safety and efficacy of overlapping sirolimus-eluting versus paclitaxel-eluting stents. Am Heart J (2008) 0.79
Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: implications for appropriate stent sizing. Am Heart J (2011) 0.79
Impact of scheduled angiographic follow-up in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Interv Cardiol (2013) 0.79
Aborted myocardial infarction after primary percutaneous coronary intervention: magnetic resonance imaging insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Am Heart J (2012) 0.78
The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect? J Am Coll Cardiol (2009) 0.78
Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial. Eur Heart J Acute Cardiovasc Care (2013) 0.78
The impact of previous revascularization on clinical outcomes in patients undergoing primary percutaneous coronary intervention. J Invasive Cardiol (2013) 0.78
Leukocyte count is a modulating factor for the mortality benefit of bivalirudin in ST-segment-elevation acute myocardial infarction: the HORIZONS-AMI trial. Circ Cardiovasc Interv (2013) 0.77
Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial). Am J Cardiol (2013) 0.77
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes. Am J Cardiol (2006) 0.76
Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry. EuroIntervention (2016) 0.76
Reply: relationship between myocardial reperfusion, infarct size, and mortality. JACC Cardiovasc Interv (2013) 0.75
CABG or PCI? An interventional cardiologist's perspective. To stent or to operate: is this the question? Cleve Clin J Med (2006) 0.75
The pain and the gain of treating patients with acute coronary syndromes-can the two be separated? Am Heart J (2009) 0.75
The accuracy of the electrocardiogram during exercise stress test based on heart size. PLoS One (2011) 0.75
Wish list and REALITY: choice of stents and end points for treatment of de novo coronary artery lesions. JAMA (2006) 0.75
Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: insights from the ACUITY trial. Int J Cardiol (2012) 0.75
Early invasive strategies for acute coronary syndromes. Curr Cardiol Rep (2002) 0.75
Flow-dependent changes resulting in restoration of patency of the left internal mammary artery graft after documented atresia. J Invasive Cardiol (2011) 0.75
Relation of myocardial perfusion to mortality after primary percutaneous coronary intervention. Am J Cardiol (2005) 0.75
GuardWire emboli protection device is associated with improved myocardial perfusion grade in saphenous vein graft intervention. Am Heart J (2004) 0.75
Primary percutaneous coronary intervention for acute MI: improving access and outcomes. Cleve Clin J Med (2005) 0.75
Cardiac Amyloidosis Presenting With Cardiogenic Shock. Am J Ther (2016) 0.75
Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency. Am J Cardiol (2002) 0.75
Efficacy and Safety of Prasugrel Compared With Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Am J Ther (2014) 0.75
Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library. Contemp Clin Trials (2008) 0.75
Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction. Am Heart J (2002) 0.75
Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial. J Invasive Cardiol (2015) 0.75
Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention. Am J Cardiol (2011) 0.75
Fogarty Maneuver to Restore Coronary Flow in ST-Segment Elevation Myocardial Infarction: Desperate Times Call for Desperate Measures. Am J Ther (2016) 0.75
Effect of uncoated stenting versus balloon angioplasty alone of long coronary (>20 mm) versus shorter narrowings on one-year event-free survival. Am J Cardiol (2003) 0.75
Reply: Treatment Strategies for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Is Staged PCI Truly the Best Option? JACC Cardiovasc Interv (2017) 0.75
Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent. Am J Cardiol (2006) 0.75
Impaired myocardial perfusion score and inflammatory markers in patients undergoing primary angioplasty for acute myocardial infarction. Arch Cardiol Mex (2007) 0.75
Recurrent coronary artery thrombosis after anomalous right coronary artery re-implantation to the aorta. Catheter Cardiovasc Interv (2013) 0.75